Cargando…

SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis

Rationale: Glioma is the most common primary malignant tumor of human central nervous system, and its rich vascular characteristics make anti-angiogenic therapy become a therapeutic hotspot. However, the existence of glioma VM makes the anti-angiogenic therapy ineffective. SUMOylation is a post-tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hao, Wang, Di, Yi, Bolong, Cai, Heng, Wang, Yipeng, Lou, Xin, Xi, Zhuo, Li, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326132/ https://www.ncbi.nlm.nih.gov/pubmed/34345216 http://dx.doi.org/10.7150/ijbs.58035

Ejemplares similares

SUMOylation of PUM2 promotes the vasculogenic mimicry of glioma cells via regulating CEBPD
por: Wang, Di, et al.
Publicado: (2020)

SUMOylation of RALY promotes vasculogenic mimicry in glioma cells via the FOXD1/DKK1 pathway
por: Cao, Shuo, et al.
Publicado: (2023)

LOXL1‐AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR‐374b‐5p/MMP14 axis
por: Yi, Bolong, et al.
Publicado: (2021)

Clinical significance of vasculogenic mimicry in human gliomas
por: Liu, Xiao-mei, et al.
Publicado: (2011)

Vasculogenic mimicry
por: Pandiar, Deepak, et al.
Publicado: (2023)

Galunisertib inhibits glioma vasculogenic mimicry formation induced by astrocytes
por: Zhang, Chao, et al.
Publicado: (2016)

Vasculogenic mimicry: a novel target for glioma therapy
por: Chen, Yin-Sheng, et al.
Publicado: (2014)

Vasculogenic mimicry in carcinogenesis and clinical applications
por: Luo, Qingxi, et al.
Publicado: (2020)

Advances and Prospects of Vasculogenic Mimicry in Glioma: A Potential New Therapeutic Target?
por: Cai, Heng, et al.
Publicado: (2020)

ZRANB2/SNHG20/FOXK1 Axis regulates Vasculogenic mimicry formation in glioma
por: Li, Xiaozhi, et al.
Publicado: (2019)

Inhibitory effects of B-cell lymphoma 2 on the vasculogenic mimicry of hypoxic human glioma cells
por: LI, JIANWEN, et al.
Publicado: (2015)

miR-141 inhibits glioma vasculogenic mimicry by controlling EphA2 expression
por: Li, Guoxiong, et al.
Publicado: (2018)

Vasculogenic Mimicry Formation Predicts Tumor Progression in Oligodendroglioma
por: Xie, Jing, et al.
Publicado: (2021)

Tenascin-c mediated vasculogenic mimicry formation via regulation of MMP2/MMP9 in glioma
por: Cai, Hai-ping, et al.
Publicado: (2019)

FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer
por: Recouvreux, Maria Sol, et al.
Publicado: (2022)

Caveolin-1 promotes tumor cell proliferation and vasculogenic mimicry formation in human glioma
por: Chen, Wenli, et al.
Publicado: (2021)

Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
por: Wei, Xiaoxu, et al.
Publicado: (2021)

Advanced research on vasculogenic mimicry in cancer
por: Qiao, Lili, et al.
Publicado: (2015)

Mechanisms of Vasculogenic Mimicry in Ovarian Cancer
por: Ayala-Domínguez, Lízbeth, et al.
Publicado: (2019)

An Overview of Vasculogenic Mimicry in Breast Cancer
por: Andonegui-Elguera, Marco A., et al.
Publicado: (2020)

Slug promoted vasculogenic mimicry in hepatocellular carcinoma
por: Sun, Dan, et al.
Publicado: (2013)

m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling
por: Liu, Xin, et al.
Publicado: (2022)

Vasculogenic mimicry in head and neck tumors: a narrative review
por: Yue, Yuan, et al.
Publicado: (2021)

Methionine aminopeptidase-2 is a pivotal regulator of vasculogenic mimicry
por: Shimizu, Shota, et al.
Publicado: (2022)

LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
por: Shao, Bing, et al.
Publicado: (2018)

Downregulation of astrocyte elevated gene-1 expression inhibits the development of vasculogenic mimicry in gliomas
por: Liang, Chen, et al.
Publicado: (2021)

N6‐methyladenosine‐modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma
por: Wu, Zhangyi, et al.
Publicado: (2022)

Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma
por: Ju, Rui-Jun, et al.
Publicado: (2016)

Number of glioma polyploid giant cancer cells (PGCCs) associated with vasculogenic mimicry formation and tumor grade in human glioma
por: Qu, Yang, et al.
Publicado: (2013)

Vasculogenic mimicry in small cell lung cancer
por: Williamson, Stuart C., et al.
Publicado: (2016)

Structural and functional identification of vasculogenic mimicry in vitro
por: Racordon, Dusan, et al.
Publicado: (2017)

Editorial: Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
por: López-Camarillo, César, et al.
Publicado: (2020)

Platelets disrupt vasculogenic mimicry by cancer cells
por: Martini, Carmela, et al.
Publicado: (2020)

Therapeutic potential of vasculogenic mimicry in urological tumors
por: Lin, Xinyu, et al.
Publicado: (2023)

Advance in vasculogenic mimicry in ovarian cancer (Review)
por: Tian, Xinyuan, et al.
Publicado: (2023)

Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry
por: Zhang, Xue, et al.
Publicado: (2019)

M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells
por: Zhang, Lin, et al.
Publicado: (2016)

Claudin-4 is required for vasculogenic mimicry formation in human breast cancer cells
por: Cui, Yong-Feng, et al.
Publicado: (2015)

Function of BMP4 in the Formation of Vasculogenic Mimicry in Hepatocellular Carcinoma
por: Li, Xiao, et al.
Publicado: (2020)

Expression of Dickkopf-1 and Twist2 in Cervical Squamous Cell Carcinoma and Their Correlation with Vasculogenic Mimicry
por: Wang, Beibei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6q5bg7lq7bq40ekrhnbie741u